Stress, distress, and bodytalk: Co-constructing formulations with patients who present with somatic symptoms

Harvard Review of Psychiatry

Volumn 21, Issue 6, 2013, Pages 314-333

  Kozlowska, Kasia ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Allostasis; Conversion disorders; Dysregulation; Functional disorders; Functional somatic symptoms; Homeostasis; Mind body interaction; Neurophysiology; Psychosomatic disorders; Stress responsivity; Stress system

Indexed keywords

OXYTOCIN; SEX HORMONE;

ABDOMINAL PAIN; ADRENERGIC SYSTEM; ARTICLE; ASTHMA; AUTONOMIC NERVOUS SYSTEM; CONCEPTUAL FRAMEWORK; DISTRESS SYNDROME; ECZEMA; FAINTNESS; FATIGUE; FUNCTIONAL DISEASE; HEART FUNCTION; HOMEOSTASIS; HUMAN; HYPERVENTILATION; IMMUNE SYSTEM; INFECTION; INTESTINE FUNCTION; MUSCULOSKELETAL PAIN; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; RESPIRATORY SYSTEM; SEIZURE; SKELETAL MUSCLE; SLEEP DISORDER; SOMNOLENCE; STRESS; THORAX PAIN; URINE RETENTION; URTICARIA;

DIAGNOSIS, DIFFERENTIAL; HOMEOSTASIS; HUMANS; SOMATOFORM DISORDERS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84896747972     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000008     Document Type: Article

References (192)

1. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332: 1351-62.
2. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 1998;840:33-44.
3. Craig AD. Forebrain emotional asymmetry: a neuroanatomical basis? Trends Cogn Sci 2005;9:566-71.
4. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol 2009;5:374-81.
5. Nader N, Chrousos GP, Kino T. Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab 2010;21:277-86.
6. Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am 2002;31:15-36.
7. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354: 1435-9.
8. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
9. Belluck P, Carey B. Psychiatry's new guide falls short, experts say. NY Times 2013;7 May: A13.
10. Insel TR. Transforming diagnosis. 2013. In: Director's blog. http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml
11. Kozlowska K. Functional somatic symptoms in childhood and adolescence. Curr Opin Psychiatry 2013;13:485-92.
12. Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary- adrenal axis. The corticotropin-releasing hormone perspective. Endocrinol Metabol Clin North Am 1992;21:833-58.
13. Koob GF, Heinrichs SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999;848:141-52.
14. Webster EL, Elenkov IJ, Chrousos GP. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol Psychiatry 1997;2:368-72.
15. Tache Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001;280:G173-7.
16. Tache Y, Perdue MH. Roleof peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004;16 suppl 1:137-42.
17. Porges SW. The polyvagal theory: neurophysiological foundations of emotions, attachment, communication, and self-regulation. New York: Norton, 2011.
18. Reiter RJ, Melchiorri D, Sewerynek E, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
19. Furlan R, Guzzetti S, Crivellaro W, et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537-47.
20. Uvanas-Moberg K, Arn I, Magnusson D. The psychobiology of emotion: the role of the oxytocinergic system. Int J Behav Med 2005;12:59-65.
21. Weitzman ED, Zimmerman JC, Czeisler CA, Ronda J. Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab 1983;56:352-8.
22. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympatheticnerve activity during sleep in normal subjects. N Engl J Med 1993;328:303-7.
23. Pervanidou P, Chrousos GP. Metabolic consequences of stress during childhood and adolescence. Metabolism 2011; 61:611-9.
24. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70.
25. Spinedi E, Gaillard RC, Chisari A. Sexual dimorphism in neuroendocrine-immune interactions. Front Horm Res 2002;29:91-107.
26. Chrousos GP. Stress and sex versus immunity and inflammation. Sci Signal 2010;3:pe36.
27. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11:411-23.
28. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999;283:1277-8.
29. Choudhry MA, Bland KI, Chaudry IH. Gender and susceptibility to sepsis following trauma. Endocr Metab Immune Disord Drug Targets 2006;6:127-35.
30. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J Clin Invest 1993;92:1896-902.
31. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev 1994;15:409-20.
32. Saper CB, Loewy AD, Swanson LW, Cowan WM. Direct hypothalamo-autonomic connections. Brain Res 1976;117: 305-12.
33. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254: 421-3.
34. Theoharides TC, Singh LK, Boucher W, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998;139:403-13.
35. Damas-Mora J, Davies L, Taylor W, Jenner FA. Menstrual respiratory changes and symptoms. Br J Psychiatry 1980; 136:492-7.
36. Lyons HA. Respiratory effects of gonadal hormones. In: Salhanick HA, Kipnis DM, Van de Wieve RL, eds. Metabolic effects of hormones in oral contraceptive steroids. New York: Plenum, 1969:394-402.
37. Lundberg U, Melin B. Stress in the development of muskuloskeletal pain. In: Linton S, ed. Avenues for the prevention of chronic muscululoskeletal pain and disability. Amsterdam: Elsevier Science, 2002:165-79.
38. Flor H, Turk DC. Chronic pain: an integrated biobehavioral approach. Seattle, WA: International Association for the Study of Pain, 2011.
39. Lanteaume L, Khalfa S, Regis J, Marquis P, Chauvel P, Bartolomei F. Emotion induction after direct intracerebral stimulations of human amygdala. Cereb Cortex 2007;17: 1307-13.
40. Hubbard D. Chronic and recurrent muscle pain: pathophysiology and treatment, a review of pharmacologic studies. J Musculoskeletal Med 1996;4:123-43.
41. Simons DG, Travell J, Simons LS. Myofascial pain and dysfunction: the trigger point manual. 2nd ed. Baltimore: Williams & Wilkins, 1999.
42. Macefield G, Burke D. Paraesthesiae and tetany induced by voluntary hyperventilation. Increased excitability of human cutaneous and motor axons. Brain 1991;114(pt 1B): 527-40.
43. Chaitow L, Bradley D, Gilbert C. Multidisciplinary approaches to breathing pattern disorders. London: Churchill Livingstone, 2002.
44. Damasio AR. Emotions and feelings. In: Self comes to mind: constructing the conscious brain. New York: Pantheon, 2010:108-29.
45. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5:617-25.
46. Dhabhar FS. Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking. Ann N Y Acad Sci 2000;917: 876-93.
47. Elenkov IJ, Chrousos GP. Stress system - organization, physiology and immunoregulation. Neuroimmunomodulation 2006;13:257-67.
48. Fleshner M. Physical activity and stress resistance: sympathetic nervous system adaptations prevent stress-induced immunosuppression. Exerc Sport Sci Rev 2005; 33:120-6.
49. Friedman EM, Irwin MR. Modulation of immune cell function by the autonomic nervous system. Pharmacol Ther 1997;74:27-38.
50. Madden KS, Felten DL. Experimental basis for neuralimmune interactions. Physiol Rev 1995;75:77-106.
51. Priftis KN, Papadimitriou A, Nicolaidou P, Chrousos GP. Dysregulation of the stress response in asthmatic children. Allergy 2009;64:18-31.
52. Elenkov IJ, Kvetnansky R, Hashiramoto A, et al. Lowversus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? J Immunol 2008;181:1737-45.
53. Craig AD. Interoception and emotion. A neuroanatmical perspective. In: Lewis M, Haviland-Jones JM, Barrett LF, eds. Handbook of emotions. 3rd ed. New York: Guilford, 2010:272-88.
54. Napadow V, Dhond R, Conti G, Makris N, Brown EN, Barbieri R. Brain correlates of autonomic modulation: combining heart rate variability with fMRI. NeuroImage 2008;42:169-77.
55. Janig W, Habler HJ. Specificity in the organization of the autonomic nervous system: a basis for precise neural regulation of homeostatic and protective body functions. Prog Brain Res 2000;122:351-67.
56. Westerhaus MJ, Loewy AD. Central representation of the sympathetic nervous system in the cerebral cortex. Brain Res 2001;903:117-27.
57. LeDoux JE, Iwata J, Cicchetti P, Reis DJ. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988;8:2517-29.
58. Damasio AR. Looking for Spinoza: joy, sorrow, and the feeling brain. Orlando, FL: Harcourt, 2003.
59. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut 1999;45 suppl 2:II6-16.
60. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62.
61. Pavlov VA, Tracey KJ. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 2006; 34:1037-40.
62. Devous MD, Husain M, Harris TS, Rush AJ. Effects of VNS on regional cerebral blood flow in depressed subjects. Eur Psychiatry 2002;17:113-4.
63. Santos J, Saperas E, Mourelle M, Antolin M, Malagelada JR. Regulation of intestinal mast cells and luminal protein release by cerebral thyrotropin-releasing hormone in rats. Gastroenterology 1996;111:1465-73.
64. Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007;117:33-40.
65. Lundgren O. Sympathetic input into the enteric nervous system. Gut 2000;47 suppl 4:iv33-5; discussion iv6.
66. Luckensmeyer GB, Keast JR. Activation of alpha- and beta-adrenoceptors by sympathetic nerve stimulation in the large intestine of the rat. J Physiol 1998;510(pt 2):549-61.
67. Rao SS, Hatfield RA, Suls JM, Chamberlain MJ. Psychological and physical stress induce differential effects on human colonic motility. Am J Gastroenterol 1998;93:985-90.
68. Bakvis P, Spinhoven P, Giltay EJ, et al. Basal hypercortisolism and trauma in patients with psychogenic nonepileptic seizures. Epilepsia 2009;51:752-95.
69. Bakvis P, Roelofs K, Kuyk J, Edelbroek PM, Swinkels WA, Spinhoven P. Trauma, stress, and preconscious threat processing in patients with psychogenic nonepileptic seizures. Epilepsia 2009;50:1001-11.
70. Bakker MJ, Boer F, Benninga MA, Koelman JH, Tijssen MA. Increased auditory startle reflex in children with functional abdominal pain. J Pediatr 2009;156:285-91.e1.
71. Cohen H, Benjamin J, Geva AB, Matar MA, Kaplan Z, Kotler M. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res 2000; 96:1-13.
72. Sack M, Hopper JW, Lamprecht F. Low respiratory sinus arrhythmia and prolonged psychophysiological arousal in posttraumatic stress disorder: heart rate dynamics and individual differences in arousal regulation. Biol Psychiatry 2004;55:284-90.
73. Tougas G, Spaziani R, Hollerbach S, et al. Cardiac autonomic function and oesophageal acid sensitivity in patients with non-cardiac chest pain. Gut 2001;49:706-12.
74. Oswald I. The benefit of sleep. Holistic Med 1987;2:137-9.
75. Al-Disi D, Al-Daghri N, Khanam L, et al. Subjective sleep duration and quality influence diet composition and circulating adipocytokines and ghrelin levels in teen-age girls. Endocr J 2010;57:915-23.
76. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J. Nocturnal cortisol release in relation to sleep structure. Sleep 1992;15:21-7.
77. Spath-Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991;29:575-84.
78. Steiger A, Holsboer F. Neuropeptides and human sleep. Sleep 1997;20:1038-52.
79. Opp MR. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv Neuroimmunol 1995;5:127-43.
80. Muller HU, Riemann D, Berger M, Muller WE. The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression. Acta Psychiatr Scand 1993;88:16-20.
81. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab 1999;84:1979-85.
82. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996;27:1318-24.
83. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens 1999;12:63-8.
84. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-200.
85. Mohamed-Ali V, Flower L, Sethi J, et al. Beta-adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 2001;86:5864-9.
86. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985;135:755s-65s.
87. Vizi ES, Orso E, Osipenko ON, Hasko G, Elenkov IJ. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 1995;68: 1263-76.
88. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004; 361:184-7.
89. De Jongh RF, Vissers KC, Meert TF, Booij LH, De Deyne CS, Heylen RJ. The role of interleukin-6 in nociception and pain. Anesth Analg 2003;96:1096-103, table of contents.
90. Edwards RR, Kronfli T, Haythornthwaite JA, Smith MT, McGuire L, Page GG. Association of catastrophizing with interleukin-6 responses to acute pain. Pain 2008; 140:135-44.
91. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
92. Kozlowska K, English M, Savage B, Chudleigh C. Multimodal rehabilitation: a mind-body, family-based intervention for children and adolescents impaired by medically unexplained symptoms. Part 1: The program. Am J Fam Ther 2012; 40:399-419.
93. Kozlowska K, English M, Savage B, et al. Multimodal rehabilitation: a mind-body, family-based intervention for children and adolescents impaired by medically unexplained symptoms. Part 2: Case studies and outcomes. Am J Fam Ther 2013;41:212-31.
94. Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N YAcad Sci 2006;1069:62-76.
95. Wright RJ. Stress and atopic disorders. J Allergy Clin Immunol 2005;116:1301-6.
96. Wright RJ, Cohen RT, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005;5:23-9.
97. Ring J, Przybilla B, Ruzicka T. Handbook of atopic eczema. 2nd ed. Berlin, New York: Springer, 2006.
98. Andersson T, Wardell K, Anderson C. Human in vivo cutaneous microdialysis: estimation of histamine release in cold urticaria. Acta Derm Venereol 1995;75:343-7.
99. Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001;70:6-16.
100. Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002; 129:161-7.
101. Tobin D, Nabarro G, Baart de la Faille M, van Vloten W, van der Putte S, Schuurman H-J. Increased number of immunoreactive nerve fibres in atopic dermatitis. J Allergy Clin Immunol 1995;90:613-22.
102. Schmid-Ott G, Jaeger B, Meyer S, Stephan E, Kapp A, Werfel T. Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. J Allergy Clin Immunol 2001; 108:455-62.
103. Gibbs DM. Hyperventilation-induced cerebral ischemia in panic disorder and effect of nimodipine. Am J Psychiatry 1992;149:1589-91.
104. Engel GL, Ferris EB, Logan M. Hyperventilation: analysis of clinical symptomatology. Ann Intern Med 1947;27:683-704.
105. Saltzman HA, Heyman A, Sieker HO. Correlation of clinical and physiologic manifestations of sustained hyperventilation. N Engl J Med 1963;268:1431-6.
106. Lum LC. The syndrome ofhabitual chronic hyperventilation. In: Hill O, ed. Modern trends in psychosomatic medicine. London: Butterworth, 1976:196-230.
107. Lempert T, Bauer M, Schmidt D. Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 1994;36:233-7.
108. Zaidi A, Clough P, Cooper P, Scheepers B, Fitzpatrick AP. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 2000;36:181-4.
109. Zaidi A, Clough P, Scheepers B, Fitzpatrick A. Treatment resistant epilepsy or convulsive syncope? BMJ 1998;317:869-70.
110. Gibbs FA, Gibbs EL, Lennox WG. Electroencephalographic response to overventilation and its relations to age. J Pediatr 1943;23:497-505.
111. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Effect of hyperventilation and mental stress on coronary blood flow in syndrome X. Brit Heart J 1993;69:516-24.
112. Girotti LA, Crosatto JR, Messuti H, et al. The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. Am J Cardiol 1982;49:834-41.
113. Kerr WJ, Gliebe PA, Dalton JW. Physical phenomena associated with anxiety states: the hyperventilation syndrome. Cal West Med 1938;48:12-6.
114. Wood P. Da Costa's syndrome (or effort syndrome). Lecture I. BMJ 1941;1:767-72.
115. Evans DW, Lum LC. Hyperventilation: an important cause of pseudoangina. Lancet 1977;309:155-7.
116. Evans DW, Lum MB. Hyperventilation as a cause of chest pain mimicking angina. Pract Cardiol 1981;7:131-9.
117. Bass C, Cawley R, Wade C, et al. Unexplained breathlessness and psychiatric morbidity in patients with normal and abnormal coronary arteries. Lancet 1983;321:605-9.
118. Mayou R. Invited review: atypical chest pain. J Psychosom Res 1989;33:393-406.
119. Chambers J, Bass C. Chest pain with normal coronary anatomy: a review of natural history and possible etiologic factors. Prog Cardiovasc Dis 1990;33:161-84.
120. Rasmussen K, Ravnsbaek J, Funch-Jensen P, Bagger JP. Oesophageal spasm in patients with coronary artery spasm. Lancet 1986;327:174-6.
121. Wheatley CE. Hyperventilation syndrome: a frequent cause of chest pain. Chest 1975;68:195-9.
122. Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978;58:56-62.
123. Fujii H, Yasue H, Okumura K, et al. Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: an echocardiographic and arteriographic study. J Am Coll Cardiol 1988;12:1184-92.
124. Lewis BI. Mechanism and management of hyperventilation syndromes. Biochem Clin 1964;4:89-96.
125. Levine HJ. Mimics of coronary heart disease. Postgrad Med 1978;64:58-62, 65-7.
126. Mortensen SA, Vilhelmsen R, Sandoe E. Prinzmetal's variant angina (PVA). Circadian variation in response to hyperventilation. Acta Med Scand Suppl 1981;644:38-41.
127. Freeman LJ, Nixon PG. Chest pain and the hyperventilation syndrome - some aetiological considerations. Postgrad Med J 1985;61:957-61.
128. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981;304:763-6.
129. Bohlen HG. Arteriolar closure mediated by hyperresponsiveness to norepinephrine in hypertensive rats. Am J Physiol 1979;236: H157-64.
130. Katon WJ. Chest pain, cardiac disease, and panic disorder. J Clin Psychiatry 1990;51 suppl:27-30; discussion 50-3.
131. Fleishman M, Scott J, Haddy FJ. Effect of pH change upon systemic large and small vessel resistance. Circ Res 1957; 5:602-6.
132. Gardin JM, Isner JM, Ronan JA Jr, Fox SM 3rd. Pseudoischemic "false positive" S-T segment changes induced by hyperventilation in patients with mitral valve prolapse. Am J Cardiol 1980;45:952-8.
133. Lary D, Goldschlager N. Electrocardiographic changes during hyperventilation resembling myocardial ischemia in patients with normal coronary arteriograms. Am Heart J 1974;87:383-90.
134. Tzivoni D, Stern Z, Keren A, Stern S. Electrocardiographic characteristics of neurocirculatory asthenia during everyday activities. Brit Heart J 1980;44:426-32.
135. Missri JC, Alexander S. Hyperventilation syndrome. A brief review. JAMA 1978;240:2093-6.
136. DeGuire S, Gevirtz R, Kawahara Y, Maguire W. Hyperventilation syndrome and the assessment of treatment for functional cardiac symptoms. Am J Cardiol 1992;70: 673-7.
137. Lawson NW, Butler GH 3rd, Ray CT. Alkalosis and cardiac arrhythmias. Anesth Analg 1973;52:951-64.
138. Lum LC. Physiological considerations in the treatment of hyperventilation syndromes. J Drug Res 1983;8:1867-72.
139. Rao SS, Gregersen H, Hayek B, Summers RW, Christensen J. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996; 124:950-8.
140. Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006;18:408-17.
141. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-65.
142. Dickman R, Fass R. Noncardiac chest pain. Clin Gastroenterol Hepatol 2006;4:558-63.
143. Wolf S. Sustained contraction of the diaphragm, the mechanism of a common type of dyspnea and precordial pain. J Clin Invest 1947;26:1201.
144. Bass C, Mayou R. Chest pain. BMJ 2002;325:588-91.
145. Anwar S, Kavey RE. Pediatric chest pain: findings on exercise stress testing. Clin Pediatr 2012;51:659-62.
146. Huffman JC, Pollack MH, Stern TA. Panic disorder and chest pain: mechanisms, morbidity, and management. Prim Care Companion J Clin Psychiatry 2002;4:54-62.
147. Kwiatek MA, Mirza F, Kahrilas PJ, Pandolfino JE. Hyperdynamic upper esophageal sphincter pressure: a manometric observation in patients reporting globus sensation. Am J Gastroenterol 2009;104:289-98.
148. Eastwood PR, Katagiri S, Shepherd KL, Hillman DR. Modulation of upper and lower esophageal sphincter tone during sleep. Sleep Med 2007;8:135-43.
149. Furukawa Y, Cook IJ, PanagopoulosV, McEvoy RD, Sharp DJ, Simula M. Relationship between sleep patterns and human colonic motor patterns. Gastroenterology 1994;107: 1372-81.
150. Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991;101:999-1006.
151. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998;42:814-22.
152. Mertz H, Naliboff B, Munakata J, NiaziN, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109: 40-52.
153. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:845-52.
154. Grundy D, Al-Chaer ED, Aziz Q, et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2006;130:1391-411.
155. Chen CL, Szczesniak MM, Cook IJ. Evidence for oesophageal visceral hypersensitivity and aberrant symptom referral in patients with globus. Neurogastroenterol Motil 2009;21:1142-e96.
156. Kozlowska K, English M, Savage B. Connecting body and mind: the first interview with somatizing patients and their families. Clin Child Psychol Psychiatr 2013;18:223-45.
157. Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci 2006;51:1026-32.
158. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445-50; quiz 660.
159. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: a community survey. Brit J Gen Pract 2004;54:495-502.
160. Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr 1996;129:220-6.
161. Ford MJ, Camilleri MJ, Hanson RB, Wiste JA, Joyner MJ. Hyperventilation, central autonomic control, and colonic tone in humans. Gut 1995;37:499-504.
162. Scott AC, Wensel R, Davos CH, et al. Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure. Eur Heart J 2004;25:1806-13.
163. Dalsgaard MK, Nybo L, Cai Y, Secher NH. Cerebral metabolism is influenced by muscle ischaemia during exercise in humans. Exp Physiol 2003;88:297-302.
164. Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 2003;13:500-5.
165. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152:S2-15.
166. Goldberg E. The wisdom paradox. New York: Gotham, 2006.
167. Karam I, Droupy S, Abd-Alsamad I, Uhl JF, Benoit G, Delmas V. Innervation of the female human urethral sphincter: 3D reconstruction of immunohistochemical studies in the fetus. Eur Urol 2005;47:627-33; discussion 34.
168. Karam I, Moudouni S, Droupy S, Abd-Alsamad I, Uhl JF, Delmas V. The structure and innervation of the male urethra: histological and immunohistochemical studies with three-dimensional reconstruction. J Anat 2005;206: 395-403.
169. Vodusek D, Light J. The motor nerve supply of the external urethral sphincter muscles: an electrophysiological study. Neurourol Urodyn 1983;2:193-200.
170. Nour S, Svarer C, Kristensen JK, Paulson OB, Law I. Cerebral activation during micturition in normal men. Brain 2000;123 (pt 4):781-9.
171. DasGupta R, Kavia RB, Fowler CJ. Cerebral mechanisms and voiding function. BJU Int 2007;99:731-4.
172. Zhang H, Reitz A, Kollias S, Summers P, Curt A, Schurch B. An fMRI study of the role of suprapontine brain structures in the voluntary voiding control induced by pelvic floor contraction. NeuroImage 2005;24:174-80.
173. Kozlowska K, Scher S, Williams LM. Patterns of emotional-cognitive functioning in pediatric conversion patients: implications for the conceptualization of conversion disorders. Psychosom Med 2011;73:775-88.
174. Hauge A, Thoresen M, Walloe L. Changes in cerebral blood flow during hyperventilation and CO2-breathing measured transcutaneously in humans by a bidirectional, pulsed, ultrasound Doppler blood velocitymeter. Acta Physiol Scand 1980;110:167-73.
175. Markwalder TM, Grolimund P, Seiler RW, Roth F, Aaslid R. Dependency of blood flow velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure - a transcranial ultrasound Doppler study. J Cereb Blood Flow Metab 1984;4:368-72.
176. Ost LG, Sterner U, Lindahl IL. Physiological responses in blood phobics. Behav Res Ther 1984;22:109-17.
177. Vaddadi G, Esler MD, Dawood T, Lambert E. Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J 2010;31:2027-33.
178. Donadio V, Liguori R, Elam M, et al. Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients. Brain 2007;130:1653-62.
179. Accurso V, Winnicki M, Shamsuzzaman AS, Wenzel A, Johnson AK, Somers VK. Predisposition to vasovagal syncope in subjects with blood/injury phobia. Circulation 2001;104:903-7.
180. Newton JL, Kenny R, Lawson J, Frearson R, Donaldson P. Prevalence of family history in vasovagal syncope and haemodynamic response to head up tilt in first degree relatives: preliminary data for the Newcastle cohort. Clin Auton Res 2003;13:22-6.
181. Bracha HS, Yoshioka DT, Masukawa NK, Stockman DJ. Evolution of the human fear-circuitry and acute sociogenic pseudoneurological symptoms: the Neolithic balancedpolymorphism hypothesis. J Affect Disord 2005;88:119-29.
182. Aybek S, Nicholson T, Zelaya F, et al. The neural correlates of recall of life events in conversion disorder. JAMA Psychiatry (forthcoming).
183. Kanaan RA, Craig TK, Wessely SC, David AS. Imaging repressed memories in motor conversion disorder. Psychosom Med 2007;69:202-5.
184. Kozlowska K. Healing the disembodied mind: contemporary models of conversion disorder. Harv Rev Psychiatry 2005; 13:1-13.
185. Bowman ES, Markand ON. The contribution of life events to pseudoseizure occurrence in adults. Bull Menninger Clin 1999;63:70-88.
186. Roelofs K, Spinhoven P, Sandijck P, Moene FC, Hoogduin KA. The impact of early trauma and recent life-events on symptom severity in patients with conversion disorder. J Nerv Ment Dis 2005;193:508-14.
187. Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain 2010;133:1526-36.
188. Kozlowska K, Rose D, Khan R, Kram S, Lane L, Collins J. A conceptual model and practice framework for managing chronic pain in children and adolescents. Harv Rev Psychiatry 2008;16:136-50.
189. Szyf M, McGowan P, Meaney MJ. The social environment and the epigenome. Environ Mol Mutagen 2008;49:46-60.
190. Hoffjan S, Nicolae D, Ostrovnaya I, et al. Gene-environment interaction effects on the development of immune responses in the 1st year of life. Am J Hum Genet 2005;76:696-704.
191. Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress: hormonal mediators and human development. Horm Res 2003;59:161-79.
192. McMillen IC, MacLaughlin SM, Muhlhausler BS, Gentili S, Duffield JL, Morrison JL. Developmental origins of adult health and disease: the role of periconceptional and foetal nutrition. Basic Clin Pharmacol Toxicol 2008;102:82-9.